Eckert & Ziegler SE (LON:0NZY)

Market Cap	921.28M
Revenue (ttm)	256.53M
Net Income (ttm)	31.41M
Shares Out	n/a
EPS (ttm)	0.50
PE Ratio	29.33
Forward PE	20.79
Dividend	0.14 (0.84%)
Ex-Dividend Date	Jun 19, 2025

Volume	2,813
Average Volume	9,847
Open	17.14
Previous Close	17.16
Day's Range	16.83 - 17.21
52-Week Range	12.29 - 23.07
Beta	1.55
RSI	40.09
Earnings Date	Nov 13, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2024
• Employees: 1,085
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NZY

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial numbers in EUR